During acute inflammation, P-selectin is transiently mobilized from Weibel-Palade bodies to the surface of histamine-activated endothelial cells, where it mediates rolling adhesion of neutrophils under hydrodynamic flow. During chronic or allergic inflammation, sustained expression of P-selectin on the endothelial cell surface has been observed. We found that the cytokines interleukin 4 (IL-4) or oncostatin M (OSM) induced a five-to ninefold increase in P-selectin messenger RNA (mlLNA) in human umbilical vein endothelial cells (HUVEC) that persisted as long as 72 h. IL-4 elevated P-selectin mRNA by increasing its transcription rate rather than by prolonging its already long half-life. Stimulation of P-selectin transcription by IL-4 or OSM required new protein synthesis and tyrosine phosphorylation of cellular proteins. Tumor necrosis factor 0r IL-113, lipopolysaccharide, or IL-3 did not increase P-selectin mlLNA in HU-VEC, and did not augment the IL-4-induced increase in P-selectin transcripts. IL-4 or OSM increased P-selectin protein on the cell surface as well as in Weibel-Palade bodies. Under flow conditions, neutrophils rolled on P-selectin expressed by IL-4-treated H UVEC, and even more neutrophils rolled on P-selectin after IL-4-treated HUVEC were stimulated with histamine. These data demonstrate that IL-4 or OSM stimulates endothelial cells to synthesize more P-selectin over prolonged periods. The increased expression of P-selectin may facilitate the emigration of leukocytes into sites of chronic or allergic inflammation.
L
eukocyte emigration into lymphoid tissues and sites of inflammation is mediated by the sequential engagement of adhesion molecules. Molecules that transmit signals to leukocytes, endothelial cells, or platelets regulate the expression and/or function of the adhesion molecules. Specific combinations of signaling and adhesion molecules may control the onset and duration of leukocyte recruitment, as well as the subclasses of leukocytes that are mobilized, during acute, chronic, or allergic inflammation (1) .
The binding of selectins to cell-surface carbohydrate ligands mediates the initial tethering and rolling of leukocytes on the vessel wall under conditions of hydrodynamic flow (2) . Subsequent leukocyte activation promotes stable adhesion through engagement of [32 integrins with Ig-like counterreceptors such as intercellular adhesion molecule (ICAM)-I 1 and ICAM-2 (1). Depending on their activa-tion state, the or4 integrins on mononuclear cells, eosinophils, and basophils mediate both tethering and stable adhesion through interactions with the Ig counterreceptors, vascular cell adhesion molecule (VCAM)-I, and mucosal addressin cell adhesion molecule-1 (3, 4) .
TNF-ci, IL-I[3, and LPS participate in acute inflammation, where neutrophils preferentially accumulate, but they may also be present at sites of chronic inflammation. These mediators stimulate endothelial cells to transcribe mRNAs encoding E-selectin, ICAM-1, and VCAM-1 (5) . In vivo, the selective expression of VCAM-1 is associated with the accumulation of mononuclear leukocytes or eosinophils during chronic or allergic inflammation (6) (7) (8) (9) (10) (11) (12) (13) . IL-4, a cytokine expressed by CD4 + T cells, basophils, and mast cells (14) (15) (16) (17) , is frequently detected at the same sites (18, 19) . In vitro, IL-4 induces human umbilical vein endothelial cells (HUVEC) to synthesize VCAM-1, but not E-selectin or ICAM-1. VCAM-1 mediates adhesion ofmononuclear cells, eosinophils, and basophils, but not neutrophils, to the endothelial cell surface (20) (21) (22) . Under shear stress, monocytes attach and roll on IL-4-activated HUVEC through interactions with VCAM-1 and with a ligand for L-selectin (23) . These data suggest that IL-4 promotes emigration of mononuclear cells or eosinophils during chronic and allergic inflammation, in part, by inducing the selective expression of VCAM-1 on the endothelium. Another potential mediator of chronic inflammation is oncostatin M (OSM), which is secreted by monocytes and activated T cells (24) . OSM stimulates release of plasminogen activator activity from bovine endothelial cells (25) and expression oflL-6 in HUVEC (26) . It is not known whether OSM alters the expression of adhesion molecules on endothelial cells. P-selectin is stored in the membranes of the a granules of platelets (27, 28) and the Weibel-Palade bodies of endothelial cells (29, 30) . Upon stimulation of these cells by agonists such as thrombin, histamine, and complement components, P-selectin is rapidly mobilized to the plasma membrane, where it mediates the adhesion of neutrophils, monocytes, eosinophils, basophils, and subsets of lymphocytes (31) (32) (33) (34) (35) (36) . The protein is then rapidly internalized (37, 38) and targeted to lysosomes for degradation (39) or, in some cases, resorted into secretory granules (40) . This rapid but self-limited surface expression enables P-selectin to mediate leukocyte tethering to the vessel wall during the earliest stages of acute inflammation (41, 42) .
Persistent expression of P-selectin on the endothelial cell surfa.ce has also been observed in tissues with chronic or allergic inflammation such as rheumatoid synovium (43) , atherosclerotic plaque (44) , and nasal polyp (45) . In vitro, TNF-a or LPS induces a two-to fourfold increase in the steady-state levels of P-selectin transcripts in murine and bovine endothelial cells (46) (47) (48) . This increased synthesis of P-selectin may saturate the sorting pathway into secretory granules, leading to direct delivery of the protein to the cell surface (47) . In vivo, TNF-a or LPS also increases the levels of P-selectin mRNA and protein in endothelial cells of mice and rats (46, (48) (49) (50) . Both in vitro and in vivo, however, the increased mRNA levels peak within 2-4 h and decline to basal levels within 12-24 h after addition of TNF-a or LPS. Thus, it is not clear whether the effects of these mediators are sufficient to account for the persistent and selective expression of P-selectin in certain tissues with chronic and allergic inflammation. Furthermore, unlike its effects in cultured rodent and bovine endothelial cells, TNF-0c does not increase P-selectin mP, NA in HUVEC (51) . These data suggest that mediators other than TNF-a and LPS might increase the transcription of P-selectin mRNA during some inflammatory responses.
In this study, we demonstrate that either IL-4 or OSM causes a sustained accumulation of P-selectin mR.NA and protein in cultured HUVEC. This mechanism to increase expression of P-selectin may facilitate the emigration of leukocytes into sites of chronic or allergic inflammation.
Materials and Methods
Reagents andAntibodies. The anti-human P-selectin mAbs $12 and G1 were characterized as described (32, 52 Cell Culture. HUVEC were isolated and cultured in medium 199 containing 20% human serum, 2 mM glutamine, 100 U/ml penicillin, and 100 pxg/ml of streptomycin as described (53) . Cells were grown to confluence on LPS-free, gelatin-coated tissue culture plastic. Passage 1 cells were used in all experiments illustrated. However, similar responses to cytokines were observed with cells studied after two or three passages. Cytokines or pharmacologic agents, dissolved in fresh medium, were added to the confluent cells for the time intervals and at the final concentrations indicated in the text. As a control, fresh medium lacking the cytokine or pharmacologic agent was added to other cells. In other experiments, Nutridoma SP serum-free medium, in the presence or absence of a cytokine, was added to the cells. As determined by Northem blot analysis, HUVEC responded similarly to cytokines whether they were dissolved in fresh medium 199 containing human serum or dissolved in Nutridoma SP serumfree medium.
Human lung microvascular endothelial cells were obtained from Clonetics (San Diego, CA) and cultured in medium supplied by the manufacturer (modified MCDB medium supplemented with 5% FBS, 12 ng/ml bovine brain extract, 10 ng/ml human epidermal growth factor, 1 ng/ml hydrocortisone, 50 Ixg/ml gentamicin, and 50 ng/rrd amphotericin). Passage 4 or 5 cells were used in all experiments illustrated. Murine bEnd.3 endothelioma cells (47) were grown in DMEM containing 10% FBS, 2 mM glutamine, 100 U/ml penicillin, and 100 Ixg/ml streptomycin. Human rmcrovascular endothelial ceils and bEnd.3 cells were treated with cytokines as described for HUVEC, except that murine IL-4 was used instead of human IL-4 to treat bEnd.3 cells. Cells used in all experiments were determined to be free of mycoplasma, as measured by a PCR-based detection system (Stratagene, San Diego, CA).
Northern Blot Analysis. Northern blot analysis of total P,.NA isolated from confluent endothelial cells was performed as described (54) . The 32p-labeled probes were a 1.4-kb SmaI fragment of human P-selectin cDNA (54), a BstXI-linearized plasmid containing a human VCAM-I-Ig cDNA chimera (55), a 2.9-kb XbaI fragment of human E-selectin cDNA (56), a BamHI-linearized plasmid containing the entire CHO-B cDNA (57) , and a HindIII-linearized CDM8 plasmid containing murine P-selectin cDNA (46) . Quantification of RNA was performed by densitometry using a Model GS-670 imaging densitometer (Bio Rad Laboratories, Hercules, CA). The scans were normalized according to the levels of CHO-B transcripts, which did not change when endothelial cells were treated with cytokines.
Nudear Run-on Analysis. HUVEC were incubated in fresh medium in the presence or absence of 20 ng/ml of IL-4 for 10 h at 37~ Cell nuclei were isolated and nuclear run-on assays were performed as described (58) . Equal amounts of 32p-labeled, newly transcribed R.NA from unstimulated or IL-4-stimulated HUVEC were hybridized with target DNAs that were immobilized on Hybond-N membranes using a Bio Rad slot-blot apparatus. The target DNAs were the SmaI fragment of human P-selectin cDNA, the linearized plasmid containing the CHO-B cDNA, or, as a negative control, the plBI20 plasmid (IBI Laboratories, New Haven, CT) lacking any cDNA insert.
Binding of 12sI-$12 to HUVEC. Binding of 125I-labeled mAb $12 to fixed or nonfixed HUVEC monolayers was performed as described (37, 59 ).
Quantification of P-Selectin by ELISA. HUVEC in six-well plates were lysed with 500 0.1 of 0.1 M sodium phosphate, pH 8.0, 1% Triton X-100, 1.5 ~g/ml aprotinin, 1 mM PMSF, 5 ~g/ml pepstatin A, 21 ~M leupeptin, and 27 mM iodoacetamide. The lysates were centrifuged at 10,000 g for 10 rain. P-selectin antigen in the supematants was measured by ELISA, using recombinant soluble P-selectin as standard (60) .
Adhesion of Neutrophils to HUVEC under Static or Flow Conditions.
Adhesion of human neutrophils to HUVEC under static conditions was performed as described (32, 53) . Neutrophil attachment to HUVEC under hydrodynamic flow conditions was measured in a parallel-plate flow chamber as described (61, 62) .
Results

Stimulation of H U V E C with IL-4 Increases m R N A for P-Selectin and V C A M -1, but Not for E-Selectin.
To determine whether IL-4 affected the amount o f P-selectin m R N A in H U V E C , we treated confluent cell monolayers with 20 ng/ml of human rlL-4 for various intervals. Steadystate levels of P-selectin m R N A were measured by N o r t he m blot analysis of equivalent amounts of R N A isolated from each group of cells. As demonstrated previously (54) , unstimulated H U V E C expressed m R N A for P-selectin ( Fig. 1 A) . IL-4 markedly increased the levels o f P-selectin m R N A . Transcripts did not accumulate until 10 h after the addition of IL-4; m R N A levels reached a maximum after 24 h and remained at this level for at least 32 h (Fig. 1 A) . In other experiments, m R N A remained at maximal levels for up to 72 h after addition of IL-4 (data not shown). The membrane was rehybridized with a probe encoding C H O -B , a ubiquitously expressed transcript that does not change its levels when cells are stimulated (57) . Quantification o f the P-selectin transcripts, normalized for the amount of C H O -B m R N A , indicated that IL-4 increased P-selectin m R N A by seven-to ninefold after 24-32 h (Fig. 1 B) . IL-4 increased P-selectin m R N A in a concentration-dependent manner, with near-maximal levels achieved at a concentration of 10 ng/ml (data not shown). The effect o f l L -4 was not caused by contamination with LPS, since boiled IL-4 did not increase P-selectin transcripts. Indeed, exogenous LPS did not alter P-selectin m R N A (Fig. 1 A) .
Rehybridization of the membrane with probes for E-selectin and V C A M -1 indicated that unstimulated H U -VEC did not express transcripts for either molecule. IL-4 induced the accumulation of m R N A for V C A M -1 , but not for E-selectin, confirming previous observations (63) . Transcripts for V C A M -1 increased more rapidly than those for P-selectin ( Fig. 1 A) . LPS markedly increased m R N A for both E-selectin and V C A M -1 .
Stimulation of H U V E C with O S M Increases m R N A for P-Selectin, but Not for E-Selectin or V C A M -1 .
Although O S M is k n o w n to stimulate H U V E C through interactions with a high affinity receptor (26) , its ability to affect expres- sion of adhesion molecules on these cells has not been studied. W e treated H U V E C with 10 ng/ml of O S M for various intervals and then measured the levels o f m R N A for P-selectin, E-selectin, and V C A M -1 by Northern blot analysis (Fig. 2) . O S M markedly increased transcripts for P-selectin in a manner much like that observed for IL-4. Transcripts did not accumulate until 10 h after addition of OSM, reached a maximum after 24-32 h, and remained at this level for up to 72 h. Densitometric analysis indicated that O S M increased m R N A levels for P-selectin by five-to sixfold. O S M increased P-selectin transcripts in a concentration-depen- Figure 2 . Stimulation of HUVEC with OSM increases mRNA for P-selectin and VCAM-1, but not for E-selectin. HUVEC were treated with fresh medium in the presence or absence of 10 ng/ml of OSM, 10 ng/ml of LPS, or 10 ng/rnl of LPS inactivated with 10 ~g/ml of polymyxin B. After the indicated time, total RNA was isolated and analyzed by Northern blotting, as described in Fig. 1 . The data are representative of three independent experiments. dent manner, with near-maximal effects at a concentration of 10 n g / m l (data n o t shown). O S M did n o t induce accumulation o f m R N A for E-selectin. U n l i k e IL-4, O S M also did not increase the levels ofVCA/VI-1 m R N A (Fig. 2) .
Costimulation of HUVEC with IL-4 Plus TNF-oe, IL-1~3, LPS, or IL-3 Does Not Further Increase mRNA for P-Selectin. Costimulation o f H U V E C with IL-4 plus TNF-oL in-
creases V C A M -1 R N A to a m u c h higher level than that induced by either individual cytokine (63) . W e stimulated H U V E C with TNF-ci, IL-113, LPS, or IL-3 for various intervals. O t h e r cells were treated with IL-4, alone or in c o m b i n a t i o n with one of the other agonists. W e then measured the levels of m R N A for P-selectin and V C A M -1 (Fig. 3) . As reported previously (6, 63, 64) , TNF-Ix increased V C A M -1 m R N A , and TNF-ot combined with IL-4 increased V C A M -1 m R N A significantly more than the level produced by either cytokine alone (Fig. 3 A) . T h e combination of IL-4 with IL-113 or LPS produced a similar synergistic increase in V C A M -1 m R N A (Fig. 3, B and C) . In contrast, TNF-ct, IL-I~, or LPS did not increase P-selectin m R N A and had little or no effect on the IL-4-induced increase in P-selectin transcripts (Fig. 3, A -C ) . In fact, these agonists sometimes decreased P-selectin m R N A levels after 10-24 h (Fig. 3 , A and C). IL-3 had little or no effect on V C A M -1 or P-selectin m R N A and did not augment the increases in these transcripts induced by IL-4 ( Fig. 3 D) .
IL-4 Does Not Detectably Affect the Half-life of P-Selectin mRNA, but Does Increase the Transcription of P-Selectin mRNA. T o determine whether IL-4 increased the steady-
state levels of P-selectin m R N A by prolonging its half-life, Figure 3 . Costimulation of HUVEC with IL-4 plus TNF-~x, IL-I~, LPS, or IL-3 does not further increase mRNA for P-selectin. HUVEC were treated with (A) TNF-~x (100 U/nil), (B) IL-113 (100 U/ml), (C) LPS (10 ng/ml), or (D) IL-3 (10 ng/ml). Other HUVEC were treated with 2(} ng/ml of IL-4, alone, or with the indicated mediator. After the indicated time, total RNA was isolated and analyzed by Northern blotting, as described in Fig.  1 . The data are representative of two (A-C) or three (D) experiments.
we pretreated H U V E C with m e d i u m in the presence or absence o f IL-4 for 24 h, and then blocked further transcription by adding actinomycin D. At intervals up to 12 h, the remaining P-selectin m R N A was detected by N o r t hern blot analysis and quantified by densitometry o f the blots (Fig. 4) . T h e half-life of P-selectin transcripts in both c o ntrol ( m e d i u m only) and IL-4-treated cells exceeded 12 h. These results indicate that P-selectin m R N A has a long half-life in both control and IL-4-treated H U V E C .
W h e n IL-4 and actinomycin D were added simultaneously to H U V E C , there was no increase in P-selectin m R N A (data not shown). T o confirm that IL-4 increased the transcription ofP-selectin ~A , we used a nuclear r u n -o n assay. T r e a t m e n t of H U V E C with IL-4 for 10 h significantly increased the transcription of m R N A for P-selectin (Fig. 5) . Densitometric analysis indicated that IL-4 increased the transcription of P-selectin m R N A by four-to fivefold (data n o t shown). (Fig. 6 ). This result Figure 5 . IL-4 increases the transcription of P-selectin mRNA. Cell nuclei were isolated from HUVEC that were pretreated with fresh medium in the presence or absence of 20 ng/rnl of IL-4 for 10 h. Equal amounts of 32p-labeled nuclear RNA from unstimnlated and IL-4-stimulated cells were hybridized with unlabeled P-selectin cD'NA, CHO-B cDNA, and a control plBI20 plasmid that were immobilized on a Hybond-N membrane with a slot blot apparatus. The data are representative of three independent experin l e n t s . supports a role for tyrosine phosphorylation in the cytok i n e -i n d u c e d expression and perhaps the constitutive expression ofP-selectin m R N A .
Inhibitors of Tyrosine Kinases Block the IL-4-and OSMinduced Increases in P-
The IL-4-and OSM-induced Accumulation of P-Selectin mRNA in H U V E C Requires Protein Synthesis.
T h e lag period required for H U V E C to accumulate P-selectin m R N A in response to IL-4 differs from the early a c c u m ulation of transcripts from immediate early genes, which cytokines activate without a requirement for n e w protein synthesis (5, 65, 66) . T o determine w h e t h e r the I L -4 -induced increase in P-selectin m R N A required protein synthesis, we stimulated H U V E C with IL-4 in the presence or absence o f cycloheximide. T h e cycloheximidetreated cells did n o t increase P-selectin m R N A in response to IL-4 (Fig. 7) . In contrast, these cells expressed higher IL-4--stimulated HUVEC. HUVEC were pretreated with fresh medium or with fresh medium plus 10 ng/ml of IL-4 for 24 h. Actinomycin D (5 vtg/rnl) was then added to block further transcription. After the indicated time, total RNA was isolated, and P-selectin mRNA was quantified by Northern blotting and densitometry. The mRNA level before addition of actinomycin D (time 0) was assigned a value of 100%, and subsequent values were normalized relative to this value. The data represent the mean + SD of three independent experiments for both control and 1L-4-treated cells. The IL-4-induced accumulation of P-selectin rn~NA in HUVEC requires protein synthesis. HUVEC were treated with fresh medium containing 20 ng/ml IL-4 in the presence or absence of 10 I.tg/ml of cycloheximide. After the indicated time, total R N A was isolated and analyzed by Northern blotting, as described in Fig. 1 . The data are representative of three independent experiments. E-selectin m R N A levels, presumably because they could not synthesize new Itd3-a to retain heterodimeric NF-KB complexes in the cytoplasm (69, 70) . These results demonstrate that, to fully activate the P-selectin gene, IL-4 must first induce the synthesis of one or more proteins in HUVEC. OSM also required protein synthesis to increase P-selectin m R N A in HUVEC (data not shown).
Stimulation of H U V E C with IL-4 or O S M Increases P-Selectin Protein.
To determine whether the IL-4-induced increase in P-selectin m K N A led to an increase in P-selectin protein, we treated HUVEC with or without IL-4 for 24 h and then measured the amount of P-selectin protein with three different assays (Fig. 8) . Using an ELISA, we found that IL-4 increased P-selectin in cell lysates by nearly threefold (Fig. 8 A) . We next compared the levels of surface and total P-selectin by measuring binding of ~2SI-labeled $12, an mAb to P-selectin, to fixed, nonpermeabilized or permeabilized cells. IL-4 increased both the surface and total levels of P-selectin, although only a small fraction of the total P-selectin was on the surface in both control and treated cells (Fig. 8 B) . We then added ~2~I-$12 to live cells at 37~ which allowed cumulative binding of the antibody to P-selectin molecules cycling between endosomes and the plasma membrane (37, 38) . IL-4 treatment increased the amount of P-selectin in these two compartments. In both control and IL-4-treated cells, stimulation with histamine further elevated P-selectin, consistent with fusion of WeibelPalade membranes with the plasma membrane (Fig. 8 C) . These data demonstrate that IL-4 increases the level of P-selectin constitutively present on the cell surface, as well as the quantity of P-selectin that can be mobilized to the plasma membrane from Weibel-Palade bodies. As measured with the same assays, OSM also increased P-selectin protein in HUVEC (data not shown).
More Neutrophils Adhere to P-Selectin on IL-4-stimulated H U V E C under Both Static and Flow
Conditions, W e n e x t asked whether the IL-4-induced increase in P-selectin protein enhanced the adhesion ofneutrophils to HUVEC. We used neutrophils because they do not express functional or4 integrins, except in response to certain stimuli (71) . Therefore, neutrophils do not interact with VCAM-1 (6, 64, 72) , which is expressed on IL-4-activated HUVEC (20) (21) (22) (23) . In static adhesion assays, few neutrophils adhered to control HUVEC (Fig. 9 A) . As observed previously (32, 73) , neutrophils adhered transiently to HUVEC stimulated with histamine; adhesion peaked 3 min after addition of histamine and then rapidly declined to basal levels. More neutrophils adhered to IL-4-treated HUVEC, even in the absence of histamine, and significantly more neutrophils transiently adhered after stimulation with histamine. Neutrophils did not attach to unstimulated HUVEC under conditions of hydrodynamic flow (Fig. 9 B) . However, neutrophils rolled on HUVEC immediately after the monolayer was stimulated with histamine, confirming previous results (74) . Neutrophils rolled on IL-4-treated HUVEC, even in the absence of histamine, and significantly more neutrophils rolled on HUVEC after stimulation with histamine (Fig. 9 B) . Neutrophil adhesion under both static and flow conditions was blocked by G1, an mAb to P-selectin, indicating that the observed adhesion was to P-selectin. These results demonstrate that neutrophils attach and roll on P-selectin that is constitutively expressed on the surface of IL-4-treated HUVEC. Treatment with histamine mobilizes additional P-selectin from Weibel-Palade bodies to the cell surface, promoting attachment of even more neutrophils.
IL-4 Increases P-Selectin mRNA in Murine Endothelial Cells and in Human Lung Microvascular Endothelial Cells. To de-
termine whether IL-4 affected P-selectin mRNA levels in endothelial cells other than HUVEC, we added IL-4 to murine bEnd.3 endothelioma cells and to human lung microvascular endothehal cells. The amounts of P-selectin or VCAM-1 mRNA were then measured by Northern blot analysis. We used murine IL-4 to stimulate bEnd.3 cells because of the restricted species specificity of IL-4 for its receptor (75) . We also used a murine P-selectin cDNA probe (46) to measure P-selectin mRNA in bEnd.3 cells. Constitutively expressed P-selectin mRNA was detected in murine bEnd.3 cells, but not in human lung microvascular endothelial cells (Fig. 10) . IL-4 increased P-selectin mRNA levels in bEnd.3 cells. The kinetics of accumulation after IL-4 treatment were different than those observed in HU-VEC; transcripts were detected after 4 h, peaked at 10 h, and persisted at this level for at least 24 h. IL-4 increased P-selectin mRNA in human lung microvascular endothelial cells; the kinetics of accumulation were similar to those in HUVEC, although much less P-selectin mRNA accumulated relative to total R.NA. IL-4 also modestly increased VCAM-1 mR.NA in the human lung microvascular endothelial cells. TNF-o~ increased P-selectin mRNA in bEnd.3 cells, consistent with previous results with other mufine endothelioma cells (46) . However, TNF-o~ did not increase P-selectin mRNA in human lung microvascular endothelial cells, although it markedly increased VCAM-1 transcripts. These data demonstrate that IL-4 increases P-selectin mRNA in murine endothehal cells and human lung microvascular endothelial cells as well as in HUVEC. In contrast, TNF-~x increases P-selectin mRNA in murine endothelial cells, but not in the human endothelial cells examined. 
D i s c u s s i o n
Megakaryocytes and venular endothelial cells constitutively synthesize P-selectin and then store it in the oL granules of platelets and the Weibel-Palade bodies of endothelium (27) (28) (29) (30) . Histamine and other secretagognes rapidly mobilize P-selectin to the cell surface, where it mediates the initial tethering and rolling of neutrophils on the vessel wall during acute inflammation (32, 41, 76) . Endothelial cells stimulated with secretagogues normally limit the time that P-selectin can function by clearing it from the surface by endocytosis (37, 38) . However, P-selectin has also been observed on the luminal surface of endothelial cells in tissues with chronic or allergic inflammation (43) (44) (45) . In these conditions, there must be mechanisms that prolong the surface expression of P-selectin. We found that IL-4 and OSM, two cytokines that are elaborated during chronic or allergic inflammation, increased P-selectin mlLNA in cultured endothelial cells for as long as 72 h. Some of the newly translated P-selectin protein reached the cell surface, where it mediated tethering of neutrophils under static or flow conditions. These data suggest that IL-4 and OSM provide a mechanism to signal sustained expression of P-selectin on the endothelial cell surface during inflammation.
In H U V E C , IL-4 increased the steady-state level of P-selectin m R N A by accelerating its transcription. Because P-selectin transcripts have a long half-life, even a brief increase in the transcription rate could ensure a prolonged accumulation ofP-selectin mlkNA. H U V E C pretreated with inhibitors of tyrosine kinases did not increase P-selectin transcripts in response to IL-4 or OSM. This is consistent with known signaling mechanisms for these cytokines, which include rapid tyrosine phosphorylation of Janus kinases and signal transducer and activator o f transcription (STAT) proteins that associate with the cytoplasmic domains ofligand-occupied receptors (65, 66) . IL-4 and OSM bind to distinct receptors, and, in cells studied to date, IL-4 causes phosphorylation of Stat6, whereas OSM causes phosphorylation of Stat3 (65, 66) . However, Stat3 and Stat6 can bind to the same regulatory element in some genes, providing a potential mechanism for the induction of P-selectin expression by either IL-4 or OSM (66, 77) . Furthemlore, both cytokines might phosphorylate c o m m o n STATs not yet described, or signal through shared mechanisms that do not involve Stats (78) . Both IL-4 and OSM required new protein synthesis to increase P-selectin mP,.NA, suggesting that the cytokines functioned indirectly by activating the gene(s) for one or more other proteins that then activated the P-selectin gene. IL-4 also increased P-selectin mP, N A in murine endothelioma cells. In these cells, transcripts accumulated and then declined somewhat earlier than in HUVEC. W e have not yet determined whether IL-4 requires new protein synthesis to increase P-selectin m R N A in murine endothelial cells.
Unlike IL-4 or OSM, the mediators TNF-<x, IL-1[3, LPS, or IL-3 had little or no effect on P-selectin m R N A in H U V E C . Furthermore, they did not augment the IL-4-induced accumulation of P-selectin R N A . In fact, TNF-ot or LPS sometimes decreased the level o f P-selectin m R N A after 10-24 h, as observed previously (51) . Whether this decline in transcripts reflects reduced synthesis or increased turnover is unknown. The inability of TNF-0L to elevate P-selectin m R N A is in contrast to a modest increase in P-selectin antigen reported on the surface of H U V E C treated with TNF-ot for 6 h, although P-selectin mR.NA levels were not measured in that study (79) . It was recently reported that IL-3 induces a 1.9-fold increase in P-selectin m R N A in H U V E C (80) . This small increase in P-selectin m R N A by IL-3 was occasionally observed in our experiments, but it was much less than that induced by IL-4 or OSM.
In contrast to their lack of effect on P-selectin m R N A in HUVEC, TNF-o~ or LPS clearly increase P-selectin mlkNA in cultured murine and bovine endothelial cells (46) . In vivo, these mediators also increase P-selectin m R N A and protein levels in rodent endothelial cells (46, (48) (49) (50) . P-selectin transcripts reach a maximum 2-4 h after stimulation and then decline to basal levels within 12-24 h (46, 48, 49) . It is possible that TNF-oL, IL-1[3, and LPS increase human P-selectin m R N A levels in vivo, but not in H U V E C or the human microvascular endothelial cells that we examined in vitro. However, P-selectin m R N A levels decline in the atria of patients after cardiopulmonary bypass, whereas m R N A levels for E-selectin and ICAM-1 increase (51). Furthermore, LPS injected intradermally in rhesus monkeys results in loss of P-selectin antigen in venular endothelial cells, whereas the antigen for E-selectin appears (81).
Thus, TNF-o~, IL-113, or LPS may not affect the P-selectin gene in primates in the same manner as the P-selectin gene in species such as mice and rats. These mediators mobilize heterodimeric NF-KB proteins from the cytoplasm to the nucleus, where they bind to KB elements of responsive genes encoding proteins such as E-selectin, ICAM-1, and VCAM-1 (5). The promoter of the human gene for P-selectin has a KB element, but it binds only homodimers of p50 or p52 (82) . This suggests that TNF-ci, IL-l[3, and LPS either do not activate the human P-selectin gene, or regulate it by a mechanism different than that used for genes with more conventional ~B elements. It will be informative to compare the putative regulatory elements in the promoters of the murine and human P-selectin genes. If there are differences in how this gene is regulated across species, functions ascribed to P-selectin in some animal models of inflammation may not apply to humans.
HUVEC do not constitutively synthesize VCAM-1, but they do express VCAM-1 in response to IL-4 (20) (21) (22) 63) . TNF-e~, IL-lJ3, or LPS also increase VCAM-1 mRNA, but with different kinetics than does IL-4 (63; this study). Any of these mediators combined with IL-4 enhances and prolongs the accumulation of VCAM-1 transcripts (63; this study). This synergy results from transcriptional activation of the VCAM-1 gene by TNF-ot (and probably IL-lJ3 and LPS) plus prolongation of the otherwise short half-life of VCAM-1 mRNA by IL-4 (63). In vivo, IL-4 may be most effective in inducing VCAM-1 expression when low levels of another mediator such as TNF-ot are also present (63) . In contrast, IL-4 may increase expression of P-selectin, even in the absence of such additional mediators. Like IL-4, OSM increases P-selectin mRNA, but unlike IL-4, it does not induce VCAM-1 mRNA. OSM might selectively increase the expression of P-selectin in the presence of low levels of TNF-o~ that are insufficient to induce transcription of VCAM-1. IL-4 suppresses the induced expression of E-selectin and ICAM-1 by TNF-ot (83) . Thus, the relative levels of IL-4, OSM, and other mediators such as TNF-ot may differentially regulate the expression of P-selectin, VCAM-1, and other adhesion molecules during chronic or allergic inflammation.
IL-4 or OSM also elevated P-selectin protein in HU-VEC, although not to the same degree as P-selectin mRNA. The relatively limited increase in protein probably reflects its complex subceUular trafficking. After synthesis, P-selectin is sorted in the trans-Golgi network for delivery to secretory granules, where it has a relatively long half-life (39) . The protein that is not sorted is delivered to the plasma membrane, where it is rapidly internalized in clathrincoated pits (37, 38) . The half-life of missorted P-selectin is short because it is efficiently delivered from endosomes to lysosomes for degradation (39) . Although some P-selectin molecules may recycle from endosomes to the trans-Golgi network and be resorted (40) , in vivo immunohistochemical studies suggest that this is a relatively minor pathway (81). An increase in the level of newly synthesized P-selectin may saturate the sorting pathway, increasing the fraction of molecules that travel directly to the cell surface and are then degraded. Thus, a large increase in P-selectin mRNA might produce a relatively hmited increase in protein.
IL-4-treated HUVEC expressed more P-selectin on the plasma membrane as well as in Weibel-Palade bodies, where it could be mobilized to the cell surface by histamine. Under static conditions, IL-4 effected only a small increase in neutrophil adhesion to P-selectin in the absence of histamine. Previous studies did not note this increase, perhaps because it was modest compared to the increased adhesion ofeosinophils, monocytes, and T cells to VCAM-1 on IL-4-treated HUVEC (21, 22) . Under flow conditions, the increase in P-selectin was sufficient to mediate rolling of neutrophils in the absence of histamine, and even more neutrophils attached after the addition of histamine. It is not yet known whether these densities of P-selectin mediate attachment of flowing eosinophils, monocytes, or T cells. These leukocytes express 0t4 integrins that interact with VCAM-1 (64, 72, 84) , which could stabilize attachment mediated by even low densities of P-selectin. Other inducible molecules such as a ligand for L-selectin may enhance tethering under flow (23) . IL-4 and OSM might also have important "priming" functions. The cytokines could chronically increase the steady-state levels of P-selectin on the plasma membrane. Subsequent challenges that generate histamine, thrombin, or complement could mobilize an additional larger pool of P-selectin to the cell surface. Pathologic mediators such as oxygen-derived radicals might further increase surface expression of P-selectin by interfering with endocytosis (85) .
In the multistep model of leukocyte recruitment, the sequential interactions of different adhesion molecules are regulated by specific signaling molecules. Different combinations of adhesion and signaling molecules may control the classes of leukocytes that emigrate into sites of inflammation, and the kinetics of their accumulation (1) . The inflammatory cytokines IL-4 and OSM have many signaling functions (14) (15) (16) (17) (24) (25) (26) . We found that they also induce a sustained increase in the expression of P-selectin in endothelial cells. This may provide a mechanism for P-selectin to mediate leukocyte adhesion, not only during acute inflammation, but also during chronic and allergic inflammation.
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